N-	B-protein
and	I-protein
C-terminal	I-protein
sequences	I-protein
control	O
degradation	O
of	O
MAD3/I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
in	O
response	O
to	O
inducers	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
.	O

The	O
proteolytic	O
degradation	O
of	O
the	O
inhibitory	B-protein
protein	I-protein
MAD3/I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
in	O
response	O
to	O
extracellular	O
stimulation	O
is	O
a	O
prerequisite	O
step	O
in	O
the	O
activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
.	O

Analysis	O
of	O
the	O
expression	O
of	O
human	B-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
protein	I-protein
in	O
stable	O
transfectants	O
of	O
mouse	B-cell_line
70Z/3	I-cell_line
cells	I-cell_line
shows	O
that	O
,	O
as	O
for	O
the	O
endogenous	O
murine	O
protein	O
,	O
exogenous	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
is	O
degraded	O
in	O
response	O
to	O
inducers	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
,	O
such	O
as	O
phorbol	O
myristate	O
acetate	O
or	O
lipopolysaccharide	O
.	O

In	O
addition	O
,	O
pretreatment	O
of	O
the	O
cells	O
with	O
the	O
proteasome	B-protein
inhibitor	O
N-Ac-Leu-Leu-norleucinal	O
inhibits	O
this	O
ligand-induced	O
degradation	O
and	O
,	O
in	O
agreement	O
with	O
previous	O
studies	O
,	O
stabilizes	O
a	O
hyperphosphorylated	O
form	O
of	O
the	O
human	B-protein
I	I-protein
kappa	I-protein
B	I-protein
alpha	I-protein
protein	I-protein
.	O

By	O
expressing	O
mutant	O
forms	O
of	O
the	O
human	O
protein	O
in	O
this	O
cell	B-cell_line
line	I-cell_line
,	O
we	O
have	O
been	O
able	O
to	O
delineate	O
the	O
sequences	O
responsible	O
for	O
both	O
the	O
ligand-induced	O
phosphorylation	O
and	O
the	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

Our	O
results	O
show	O
that	O
deletion	O
of	O
the	O
C	B-protein
terminus	I-protein
of	O
the	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
molecule	O
up	O
to	O
amino	B-protein
acid	I-protein
279	I-protein
abolishes	O
constitutive	O
but	O
not	O
ligand-inducible	O
phosphorylation	O
and	O
inhibits	O
ligand-inducible	O
degradation	O
.	O

Further	O
analysis	O
reveals	O
that	O
the	O
inducible	O
phosphorylation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
maps	O
to	O
two	O
serines	O
in	O
the	O
N	B-protein
terminus	I-protein
of	O
the	O
protein	O
(	O
residues	O
32	O
and	O
36	O
)	O
and	O
that	O
the	O
mutation	O
of	O
either	O
residue	O
is	O
sufficient	O
to	O
abolish	O
ligand-induced	O
degradation	O
,	O
whereas	O
both	O
residues	O
must	O
be	O
mutated	O
to	O
abolish	O
inducible	O
phosphorylation	O
of	O
the	O
protein	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGy	NULL
,	NULL
Oct.	NULL
1995	NULL
,	NULL
p.	NULL
5339-5345	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

10	NULL
N-	NULL
and	NULL
C-Terminal	NULL
Sequences	NULL
Control	NULL
Degradation	NULL
of	NULL
MAD3/IxBa	NULL
in	NULL
Response	NULL
to	NULL
Inducers	NULL
of	NULL
NF-	NULL
«	NULL
kB	NULL
Activity	NULL
SIMON	NULL
T.	NULL
WHITESIDE	NULL
,	NULL
'	NULL
MARY	NULL
K.	NULL
ERNST	NULL
,	NULL
``	NULL
ODILE	NULL
LeBAIL	NULL
,	NULL
'	NULL
CHRISTINE	NULL
LAURENT-WINTER	NULL
,	NULL
*	NULL
NANCY	NULL
RICE	NULL
,	NULL
``	NULL
anp	NULL
ALAIN	NULL
ISRAEL	NULL
'	NULL
!	NULL

*	NULL
Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
de	NULL
l'Expression	NULL
Génique	NULL
,	NULL
URA	NULL
1149	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
``	NULL
and	NULL
Laboratoire	NULL
d	NULL
Electrophorese	NULL
Bi-dimensionelle	NULL
,	NULL
``	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
,	NULL
and	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
and	NULL
Carcinogenesis	NULL
,	NULL
ABL-Basic	NULL
Research	NULL
Program	NULL
,	NULL
NCI	NULL
Frederick	NULL
Cancer	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
Maryland	NULL
21702-1201	NULL
Received	NULL
19	NULL
April	NULL
1995/Returned	NULL
for	NULL
modification	NULL
23	NULL
May	NULL
1995/Accepted	NULL
19	NULL
July	NULL
1995	NULL
The	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
inhibitory	NULL
protein	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
is	NULL
a	NULL
prerequisite	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
IxBa	NULL
protein	NULL
in	NULL
stable	NULL
transfectants	NULL
of	NULL
mouse	NULL
70Z/3	NULL
cells	NULL
shows	NULL
that	NULL
,	NULL
as	NULL
for	NULL
the	NULL
endogenous	NULL
murine	NULL
protein	NULL
,	NULL
exogenous	NULL
IxBa	NULL
is	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
inducers	NULL
of	NULL
NF-KB	NULL
activity	NULL
,	NULL
such	NULL
as	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
or	NULL
lipopolysaccharide	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
N-Ac-Leu-Leu-norleucinal	NULL
inhibits	NULL
this	NULL
ligand-induced	NULL
degradation	NULL
and	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
stabilizes	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
the	NULL
human	NULL
IxBa	NULL
protein	NULL
.	NULL

By	NULL
expressing	NULL
mutant	NULL
forms	NULL
of	NULL
the	NULL
human	NULL
protein	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
have	NULL
been	NULL
able	NULL
to	NULL
delineate	NULL
the	NULL
sequences	NULL
responsible	NULL
for	NULL
both	NULL
the	NULL
ligand-induced	NULL
phosphorylation	NULL
and	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
IxBa	NULL
molecule	NULL
up	NULL
to	NULL
amino	NULL
acid	NULL
279	NULL
abolishes	NULL
constitutive	NULL
but	NULL
not	NULL
ligand-inducible	NULL
phosphorylation	NULL
and	NULL
inhibits	NULL
ligand-inducible	NULL
degradation	NULL
.	NULL

Further	NULL
analysis	NULL
reveals	NULL
that	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
maps	NULL
to	NULL
two	NULL
serines	NULL
in	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
residues	NULL
32	NULL
and	NULL
36	NULL
)	NULL
and	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
either	NULL
residue	NULL
is	NULL
sufficient	NULL
to	NULL
abolish	NULL
ligand-induced	NULL
degradation	NULL
,	NULL
whereas	NULL
both	NULL
residues	NULL
must	NULL
be	NULL
mutated	NULL
to	NULL
abolish	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
treatment	NULL
of	NULL
70Z	NULL
%	NULL
/3	NULL
cells	NULL
with	NULL
either	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
or	NULL
lipopolysac-charide	NULL
induces	NULL
a	NULL
kinase	NULL
activity	NULL
which	NULL
phosphorylates	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
and	NULL
that	NULL
these	NULL
phosphorylations	NULL
target	NULL
the	NULL
protein	NULL
for	NULL
rapid	NULL
proteolytic	NULL
degradation	NULL
,	NULL
possibly	NULL
by	NULL
the	NULL
ubiquitin-268	NULL
proteasome	NULL
pathway	NULL
,	NULL
thus	NULL
allowing	NULL
NF-B	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65/ReIA	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
)	NULL
bind	NULL
specifically	NULL
as	NULL
homo-	NULL
or	NULL
heterodimers	NULL
to	NULL
kB	NULL
motifs	NULL
located	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
that	NULL
control	NULL
various	NULL
aspects	NULL
of	NULL
the	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
(	NULL
including	NULL
the	NULL
major	NULL
histocompat-ibility	NULL
complex	NULL
class	NULL
I	NULL
genes	NULL
,	NULL
the	NULL
immunoglobulin	NULL
x	NULL
light	NULL
chain	NULL
,	NULL
interleukin	NULL
2	NULL
and	NULL
its	NULL
receptor	NULL
,	NULL
interleukins	NULL
6	NULL
and	NULL
8	NULL
,	NULL
granulo-cyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
beta	NULL
interferon	NULL
,	NULL
and	NULL
T-cell	NULL
receptor	NULL
B	NULL
chain	NULL
)	NULL
as	NULL
well	NULL
as	NULL
those	NULL
of	NULL
several	NULL
viruses	NULL
,	NULL
including	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
and	NULL
cytomegalovirus	NULL
(	NULL
for	NULL
recent	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
2	NULL
and	NULL
32	NULL
)	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
NF-kB	NULL
is	NULL
maintained	NULL
in	NULL
an	NULL
inactive	NULL
,	NULL
cytoplasmic	NULL
state	NULL
in	NULL
complexes	NULL
with	NULL
members	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
IxBa	NULL
,	NULL
IBB	NULL
,	NULL
and	NULL
IxBy	NULL
(	NULL
only	NULL
B	NULL
cells	NULL
and	NULL
some	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
or	NULL
macrophage	NULL
lineage	NULL
exhibit	NULL
constitutive	NULL
nuclear	NULL
NF-kB	NULL
activity	NULL
)	NULL
.	NULL

These	NULL
inhibitors	NULL
all	NULL
contain	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
motif	NULL
,	NULL
the	NULL
ankyrin	NULL
repeat	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
and	NULL
inhibit	NULL
the	NULL
nuclear	NULL
localization	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proteins	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
3	NULL
)	NULL
.	NULL

NF-kB	NULL
is	NULL
induced	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
including	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
[	NULL
PMA	NULL
]	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
interleukin	NULL
1	NULL
,	NULL
li-popolysaccharide	NULL
[	NULL
LPS	NULL
]	NULL
,	NULL
viral	NULL
infection	NULL
,	NULL
and	NULL
many	NULL
mitogens	NULL
and	NULL
cytokines	NULL
)	NULL
through	NULL
a	NULL
mechanism	NULL
involving	NULL
inactivation	NULL
of	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
de	NULL
'Expression	NULL
Génique	NULL
,	NULL
URA	NULL
1149	NULL
CNRS	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
25	NULL
rue	NULL
du	NULL
Dr.	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
85	NULL
53	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
1	NULL
40	NULL
61	NULL
30	NULL
40	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
aisraecl	NULL
@	NULL
pas	NULL
teur.fr	NULL
.	NULL

5339	NULL
IxBa	NULL
by	NULL
proteolytic	NULL
degradation	NULL
,	NULL
thus	NULL
enabling	NULL
free	NULL
NF-kB	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
to	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
20	NULL
,	NULL
26	NULL
,	NULL
31	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
proteasome	NULL
inhibitors	NULL
has	NULL
shown	NULL
that	NULL
IxBa	NULL
becomes	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
although	NULL
this	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
,	NULL
per	NULL
se	NULL
,	NULL
to	NULL
dissociate	NULL
the	NULL
inhibitor	NULL
from	NULL
the	NULL
NF-kB	NULL
complex	NULL
.	NULL

It	NULL
is	NULL
believed	NULL
that	NULL
this	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
is	NULL
the	NULL
substrate	NULL
for	NULL
proteolytic	NULL
degradation	NULL
,	NULL
which	NULL
probably	NULL
occurs	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
NF-xkB/IkxB	NULL
complex	NULL
(	NULL
1	NULL
,	NULL
9	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
domains	NULL
of	NULL
IxBa	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
Rel	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
for	NULL
inhibition	NULL
of	NULL
their	NULL
binding	NULL
to	NULL
DNA	NULL
have	NULL
been	NULL
well	NULL
characterized	NULL
(	NULL
see	NULL
reference	NULL
10	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
the	NULL
domains	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
responsible	NULL
for	NULL
degradation	NULL
and	NULL
to	NULL
map	NULL
the	NULL
sites	NULL
of	NULL
ligand-induced	NULL
phosphorylation	NULL
,	NULL
we	NULL
have	NULL
taken	NULL
advantage	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
mouse	NULL
702Z/3	NULL
cells	NULL
,	NULL
human	NULL
IxBa	NULL
expressed	NULL
from	NULL
a	NULL
stably	NULL
transfected	NULL
construct	NULL
is	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
N-Ac-Leu-Leu-norleucinal	NULL
(	NULL
ALLN	NULL
)	NULL
blocks	NULL
this	NULL
induced	NULL
degradation	NULL
and	NULL
stabilizes	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
the	NULL
transfected	NULL
IxBa	NULL
protein	NULL
.	NULL

Mutagenesis	NULL
of	NULL
the	NULL
human	NULL
IxBa	NULL
reveals	NULL
that	NULL
sequences	NULL
C	NULL
terminal	NULL
of	NULL
the	NULL
ankyrin	NULL
repeats	NULL
contain	NULL
sites	NULL
of	NULL
constitutive	NULL
phosphorylation	NULL
,	NULL
while	NULL
inducible	NULL
hyperphos-phorylation	NULL
takes	NULL
place	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
.	NULL

The	NULL
phosphorylation	NULL
of	NULL
both	NULL
of	NULL
these	NULL
residues	NULL
is	NULL
apparently	NULL
required	NULL
for	NULL
the	NULL
transfected	NULL
IxBa	NULL
protein	NULL
to	NULL
be	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
such	NULL
as	NULL
PMA	NULL
or	NULL
LPS	NULL
,	NULL
a	NULL
process	NULL
which	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
C-terminal	NULL
PEST	NULL
sequences	NULL
(	NULL
sequences	NULL
rich	NULL
in	NULL
P	NULL
,	NULL
E	NULL
,	NULL
D	NULL
,	NULL
S	NULL
,	NULL
and	NULL
T	NULL
)	NULL
of	NULL
IxBa	NULL
.	NULL

5340	NULL
WHITESIDE	NULL
ET	NULL
AL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

Hela	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
minimal	NULL
essential	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
.	NULL

a	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
50	NULL
M	NULL
B-mercaptocthanol	NULL
.	NULL

Antisera	NULL
.	NULL

The	NULL
antisera	NULL
used	NULL
were	NULL
the	NULL
following	NULL
(	NULL
see	NULL
also	NULL
references	NULL
26	NULL
and	NULL
27	NULL
)	NULL
.	NULL

Anti-c-Rel	NULL
antisera	NULL
were	NULL
1050	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
438	NULL
to	NULL
455	NULL
of	NULL
the	NULL
murine	NULL
protein	NULL
,	NULL
and	NULL
1051	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
498	NULL
to	NULL
513	NULL
of	NULL
murine	NULL
c-Rel	NULL
.	NULL

Anti-RelA	NULL
antisera	NULL
were	NULL
1207	NULL
(	NULL
ReIAN	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
18	NULL
of	NULL
the	NULL
human	NULL
protein	NULL
,	NULL
and	NULL
1226	NULL
(	NULL
ReIAC	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
537	NULL
to	NULL
550	NULL
of	NULL
human	NULL
RelA	NULL
.	NULL

Anti-IxBa	NULL
«	NULL
antisera	NULL
were	NULL
1309	NULL
(	NULL
anti-IxBaN	NULL
)	NULL
and	NULL
296	NULL
(	NULL
anti-IxBaC	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
17	NULL
and	NULL
310	NULL
to	NULL
317	NULL
of	NULL
human	NULL
IxBa	NULL
«	NULL
respectively	NULL
.	NULL

Other	NULL
antisera	NULL
were	NULL
751	NULL
(	NULL
anti-murine	NULL
IxBa	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
15	NULL
of	NULL
murine	NULL
IxBa	NULL
;	NULL
32	NULL
(	NULL
anti-rat	NULL
IxBa	NULL
)	NULL
,	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
48	NULL
to	NULL
65	NULL
of	NULL
rat	NULL
IxBa	NULL
;	NULL
and	NULL
48068	NULL
,	NULL
raised	NULL
against	NULL
recombinant	NULL
human	NULL
IxBa	NULL
«	NULL
.	NULL

Serum	NULL
1309	NULL
recognizes	NULL
human	NULL
IxBa	NULL
much	NULL
better	NULL
than	NULL
it	NULL
does	NULL
mouse	NULL
IxBa	NULL
,	NULL
and	NULL
the	NULL
reverse	NULL
is	NULL
true	NULL
for	NULL
serum	NULL
751	NULL
.	NULL

The	NULL
S7	NULL
antiserum	NULL
(	NULL
anti-IxBa	NULL
)	NULL
,	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
T.	NULL
Hay	NULL
(	NULL
St.	NULL
Andrews	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
,	NULL
was	NULL
raised	NULL
against	NULL
recombinant	NULL
human	NULL
I	NULL
«	NULL
Be	NULL
.	NULL

Plasmids	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
transfection	NULL
into	NULL
70Z	NULL
,	NULL
/3	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
subcloning	NULL
cDNAs	NULL
encoding	NULL
IxB	NULL
«	NULL
or	NULL
its	NULL
derivatives	NULL
into	NULL
the	NULL
plasmid	NULL
pRe-CMV	NULL
(	NULL
InVitrogen	NULL
)	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
mutants	NULL
were	NULL
first	NULL
cloned	NULL
into	NULL
the	NULL
plasmid	NULL
pT7Bplink	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
then	NULL
the	NULL
fragment	NULL
containing	NULL
the	NULL
B-globin	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
UTR	NULL
)	NULL
and	NULL
IxBa	NULL
encoding	NULL
sequences	NULL
was	NULL
recloned	NULL
into	NULL
pRe-CMV	NULL
.	NULL

Deletions	NULL
of	NULL
IxBa	NULL
were	NULL
produced	NULL
either	NULL
by	NULL
utilization	NULL
of	NULL
restriction	NULL
sites	NULL
or	NULL
by	NULL
digestion	NULL
with	NULL
Exolll	NULL
.	NULL

Mutations	NULL
of	NULL
IxBa	NULL
were	NULL
constructed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
with	NULL
PCR	NULL
or	NULL
with	NULL
the	NULL
Bio-Rad	NULL
Muta-Gene	NULL
Phagemid	NULL
In	NULL
Vitro	NULL
Mutagenesis	NULL
system	NULL
,	NULL
version	NULL
2	NULL
(	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotides	NULL
is	NULL
available	NULL
from	NULL
us	NULL
upon	NULL
re-quest	NULL
)	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
fragment	NULL
were	NULL
cloned	NULL
into	NULL
either	NULL
pRe-CMV	NULL
or	NULL
pCDNA3	NULL
(	NULL
InVitrogen	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
linearized	NULL
with	NULL
Bg/II	NULL
before	NULL
transfection	NULL
by	NULL
electroporation	NULL
into	NULL
70Z/3	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
.	NULL

To	NULL
prepare	NULL
crude	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
50	NULL
wl	NULL
of	NULL
Dignam	NULL
buffer	NULL
A	NULL
supplemented	NULL
with	NULL
5	NULL
mM	NULL
NaF	NULL
,	NULL
2.5	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
2.5	NULL
mM	NULL
orthophosphate	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
2	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
clean	NULL
tube	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
a	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Transfections	NULL
.	NULL

70Z/3	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
0.5	NULL
ml	NULL
,	NULL
and	NULL
then	NULL
the	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
4-mm	NULL
cuvettes	NULL
with	NULL
a	NULL
Eurogentec	NULL
Cellject	NULL
eletropo-rator	NULL
at	NULL
260	NULL
V	NULL
,	NULL
1500	NULL
wF	NULL
,	NULL
and	NULL
infinite	NULL
resistance	NULL
.	NULL

Cells	NULL
were	NULL
diluted	NULL
into	NULL
4	NULL
ml	NULL
of	NULL
complete	NULL
medium	NULL
and	NULL
were	NULL
left	NULL
to	NULL
recover	NULL
overnight	NULL
before	NULL
addition	NULL
of	NULL
0.7	NULL
mg	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

Once	NULL
established	NULL
,	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
medium	NULL
supplemented	NULL
with	NULL
0.3	NULL
mg	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

Two-dimensional	NULL
(	NULL
2D	NULL
)	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
25	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
600	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
made	NULL
up	NULL
to	NULL
30	NULL
pl	NULL
of	NULL
Dignam	NULL
buffer	NULL
A	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
B-mercaptocthanol	NULL
and	NULL
0.3	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
and	NULL
then	NULL
flash-frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

After	NULL
lyophilization	NULL
,	NULL
samples	NULL
were	NULL
resuspended	NULL
in	NULL
30	NULL
pl	NULL
of	NULL
sample	NULL
buffer	NULL
(	NULL
9.95	NULL
M	NULL
urea	NULL
,	NULL
4	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
2	NULL
%	NULL
ampholyte	NULL
[	NULL
pH	NULL
5	NULL
to	NULL
7	NULL
]	NULL
,	NULL
and	NULL
100	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
and	NULL
centrifuged	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
loaded	NULL
onto	NULL
the	NULL
isoelectrofocusing	NULL
gel	NULL
(	NULL
pH	NULL
range	NULL
,	NULL
4	NULL
to	NULL
8	NULL
;	NULL
Millipore	NULL
Corporation	NULL
)	NULL
and	NULL
run	NULL
for	NULL
20,000	NULL
V	NULL
-h.	NULL
The	NULL
second	NULL
dimension	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
on	NULL
a	NULL
12.5	NULL
%	NULL
acrylamide	NULL
gel	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Relative	NULL
isoelectric	NULL
points	NULL
were	NULL
determined	NULL
by	NULL
parallel	NULL
migration	NULL
of	NULL
a	NULL
carbamylated	NULL
muscle	NULL
creatine	NULL
phosphokinase	NULL
standard	NULL
(	NULL
BDH	NULL
)	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
molecular	NULL
masses	NULL
of	NULL
the	NULL
proteins	NULL
were	NULL
determined	NULL
according	NULL
to	NULL
molecular	NULL
weight	NULL
markers	NULL
applied	NULL
to	NULL
an	NULL
adjacent	NULL
slot	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

After	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
proteins	NULL
were	NULL
blotted	NULL
as	NULL
they	NULL
were	NULL
for	NULL
one-dimensional	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Immunoblots	NULL
.	NULL

Immunoblots	NULL
were	NULL
incubated	NULL
with	NULL
anti-IkBe	NULL
sera	NULL
diluted	NULL
1:1,000	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
revealed	NULL
with	NULL
the	NULL
Amersham	NULL
ECL	NULL
system	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

70Z/3	NULL
cells	NULL
were	NULL
metabolically	NULL
labelled	NULL
with	NULL
either	NULL
Jcysteine	NULL
or	NULL
*°P	NULL
;	NULL
and	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
immune	NULL
complexes	NULL
were	NULL
precipitated	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Cells	NULL
from	NULL
the	NULL
cell	NULL
line	NULL
293	NULL
were	NULL
metabolically	NULL
labelled	NULL
and	NULL
immune	NULL
complexes	NULL
were	NULL
precipitated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Thrombin	NULL
treatment	NULL
.	NULL

Thrombin	NULL
treatment	NULL
of	NULL
immune	NULL
complexes	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
MacKichan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
182	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
of	NULL
70Z/3	NULL
clones	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
10	NULL
mg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
M	NULL
ALLN	NULL
,	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
antiserum	NULL
296	NULL
directed	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
The	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
carrying	NULL
the	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
radioimmunoprecipitation	NULL
assay	NULL
buffer	NULL
without	NULL
SDS	NULL
and	NULL
then	NULL
were	NULL
subjected	NULL
to	NULL
three	NULL
washes	NULL
in	NULL
thrombin	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-HC	NULL
]	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2.5	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
resuspension	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
thrombin	NULL
buffer	NULL
containing	NULL
3	NULL
U	NULL
of	NULL
thrombin	NULL
,	NULL
digestion	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
2	NULL
to	NULL
16	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

All	NULL
buffers	NULL
contained	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
16.5	NULL
%	NULL
Tricine	NULL
gel	NULL
(	NULL
29	NULL
)	NULL
which	NULL
was	NULL
then	NULL
transferred	NULL
onto	NULL
an	NULL
Immobilon	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blotted	NULL
with	NULL
antiserum	NULL
1309	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IB	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
70Z/3	NULL
-	NULL
hulxBoWT	NULL
Fp	NULL
-	NULL
--	NULL
--	NULL
o-	NULL
$	NULL
-	NULL
$	NULL
-	NULL
$	NULL
ALLN	NULL
0	NULL
0	NULL
0	NULL
P	NULL
P	NULL
L	NULL
L	NULL
hn	NULL
_	NULL
ese	NULL
cc	NULL
<	NULL
e	NULL
|	NULL
-	NULL
hu*	NULL
mu	NULL
-	NULL
~	NULL
<	NULL
--	NULL
-B	NULL
hulxBaWT	NULL
_	NULL
702/3	NULL
m-0	NULL
-	NULL
4	NULL
0	NULL
-	NULL
4+	NULL
LPS	NULL
p105	NULL
-	NULL
«	NULL
«	NULL
--	NULL
-	NULL
«	NULL
k/	NULL
-	NULL
@	NULL
C	NULL
@	NULL
em0	NULL
0	NULL
®	NULL
RelA	NULL
hu	NULL
__	NULL
mu	NULL
-®®	NULL
®	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
70Z/3	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
plasmid	NULL
alone	NULL
(	NULL
70Z/3	NULL
)	NULL
or	NULL
cells	NULL
expressing	NULL
human	NULL
IxBa	NULL
(	NULL
hul	NULL
«	NULL
xBaWT	NULL
)	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
then	NULL
were	NULL
pelleted	NULL
,	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
ALLN	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
or	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
,	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-IxBa	NULL
antiserum	NULL
$	NULL
7	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
murine	NULL
(	NULL
mu	NULL
)	NULL
,	NULL
human	NULL
(	NULL
hu	NULL
)	NULL
,	NULL
and	NULL
more	NULL
slowly	NULL
migrating	NULL
hyperphosphorylated	NULL
human	NULL
(	NULL
hu*	NULL
)	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
70Z/3	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
plasmid	NULL
alone	NULL
(	NULL
70Z/3	NULL
)	NULL
or	NULL
cells	NULL
expressing	NULL
human	NULL
IxBe	NULL
(	NULL
hul	NULL
«	NULL
BaWT	NULL
)	NULL
were	NULL
labelled	NULL
for	NULL
1	NULL
h	NULL
with	NULL
100	NULL
Ci	NULL
of	NULL
1-	NULL
[	NULL
*°8Jcysteine-1-	NULL
[	NULL
**SJmethionine	NULL
per	NULL
ml	NULL
and	NULL
then	NULL
were	NULL
diluted	NULL
into	NULL
prewarmed	NULL
,	NULL
complete	NULL
medium	NULL
containing	NULL
50	NULL
mM	NULL
1-cysteine-t-methionine	NULL
.	NULL

One	NULL
third	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
immediately	NULL
(	NULL
0	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
cells	NULL
were	NULL
either	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
for	NULL
90	NULL
min	NULL
(	NULL
+	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
before	NULL
being	NULL
lysed	NULL
in	NULL
TNT	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
then	NULL
the	NULL
supernatants	NULL
were	NULL
precipitated	NULL
with	NULL
anti-Rel	NULL
(	NULL
1050	NULL
)	NULL
and	NULL
anti-ReIA	NULL
(	NULL
1226	NULL
)	NULL
antisera	NULL
.	NULL

After	NULL
being	NULL
washed	NULL
,	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
the	NULL
corresponding	NULL
peptides	NULL
and	NULL
then	NULL
were	NULL
reprecipitated	NULL
with	NULL
anti-Rel	NULL
(	NULL
1051	NULL
)	NULL
and	NULL
anti-ReIA	NULL
(	NULL
1207	NULL
)	NULL
antisera	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
p105	NULL
,	NULL
c-Rel	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
human	NULL
(	NULL
hu	NULL
)	NULL
and	NULL
murine	NULL
(	NULL
mu	NULL
)	NULL
IxBe	NULL
proteins	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

RESULTS	NULL
A	NULL
stably	NULL
transfected	NULL
IxBa	NULL
protein	NULL
is	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
responsible	NULL
for	NULL
its	NULL
degradation	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
utilize	NULL
a	NULL
system	NULL
in	NULL
which	NULL
mouse	NULL
70Z/3	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
plasmids	NULL
expressing	NULL
human	NULL
IxBa	NULL
protein	NULL
.	NULL

Endogenous	NULL
murine	NULL
IxBa	NULL
and	NULL
the	NULL
human	NULL
IxBa	NULL
could	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
different	NULL
mobilities	NULL
after	NULL
SDS-PAGE	NULL
(	NULL
compare	NULL
the	NULL
first	NULL
two	NULL
lanes	NULL
of	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
chosen	NULL
(	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
)	NULL
has	NULL
a	NULL
weak	NULL
activity	NULL
in	NULL
70Z/3	NULL
cells	NULL
,	NULL
and	NULL
thus	NULL
the	NULL
levels	NULL
of	NULL
transfected	NULL
protein	NULL
do	NULL
not	NULL
differ	NULL
greatly	NULL
from	NULL
those	NULL
seen	NULL
for	NULL
the	NULL
endogenous	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

A	NULL
cell	NULL
line	NULL
expressing	NULL
the	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
human	NULL
IxBa	NULL
protein	NULL
was	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
LPS	NULL
,	NULL
and	NULL
the	NULL
two	NULL
IxBa	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
both	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IxBa	NULL
proteins	NULL
are	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
these	NULL
stimuli	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
immunoprecipitation	NULL
with	NULL
anti-ReIA	NULL
and	NULL
anti-c-Rel	NULL
antibodies	NULL
demonstrates	NULL
that	NULL
the	NULL
transfected	NULL
IxBa	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
Rel	NULL
proteins	NULL
to	NULL
an	NULL
extent	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
murine	NULL
protein	NULL
and	NULL
that	NULL
IxBa	NULL
undergoes	NULL
degradation	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
endogenous	NULL
murine	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Immunodepletions	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
antisera	NULL
directed	NULL
against	NULL
p50	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
c-Rel	NULL
resulted	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
hulxBoA268C	NULL
[	NULL
-o	NULL
o	NULL
$	NULL
oe	NULL
o	NULL
$	NULL
o-	NULL
+	NULL
ALLN	NULL
0	NULL
0	NULL
P	NULL
P	NULL
L	NULL
L	NULL
C	NULL
``	NULL
«	NULL
MU	NULL
--	NULL
-	NULL
»	NULL
«	NULL
A	NULL
—————¢—	NULL
‘	NULL
_=A*	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
A268C	NULL
mutant	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
then	NULL
were	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
ALLN	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
or	NULL
10	NULL
jg	NULL
of	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
IxBa	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
endogenous	NULL
murine	NULL
(	NULL
mu	NULL
)	NULL
,	NULL
transfected	NULL
human	NULL
A268C	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
electrophoretically	NULL
retarded	NULL
human	NULL
A268C	NULL
(	NULL
A*	NULL
)	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
A*	NULL
band	NULL
sometimes	NULL
appears	NULL
as	NULL
a	NULL
doublet	NULL
,	NULL
but	NULL
this	NULL
result	NULL
has	NULL
not	NULL
been	NULL
found	NULL
consistently	NULL
.	NULL

in	NULL
about	NULL
10	NULL
%	NULL
of	NULL
transfected	NULL
WT	NULL
IxBa	NULL
being	NULL
left	NULL
in	NULL
the	NULL
supernatant	NULL
(	NULL
compared	NULL
with	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
IxBa	NULL
left	NULL
in	NULL
the	NULL
supernatant	NULL
when	NULL
a	NULL
preimmune	NULL
serum	NULL
was	NULL
used	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
result	NULL
was	NULL
the	NULL
same	NULL
for	NULL
the	NULL
endogenous	NULL
murine	NULL
IxBa	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
free	NULL
IxBa	NULL
are	NULL
comparable	NULL
for	NULL
both	NULL
transfected	NULL
and	NULL
endogenous	NULL
proteins	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
results	NULL
obtained	NULL
by	NULL
others	NULL
(	NULL
1	NULL
,	NULL
9	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
23	NULL
,	NULL
36	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
stabilization	NULL
of	NULL
both	NULL
murine	NULL
and	NULL
human	NULL
proteins	NULL
after	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
ALLN	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
compared	NULL
with	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
,	NULL
respec-tively	NULL
)	NULL
;	NULL
the	NULL
murine	NULL
protein	NULL
is	NULL
somehow	NULL
less	NULL
sensitive	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
ALLN	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
by	NULL
others	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2A	NULL
of	NULL
reference	NULL
6	NULL
)	NULL
.	NULL

Human	NULL
IxBa	NULL
also	NULL
exhibits	NULL
a	NULL
characteristic	NULL
upshift	NULL
in	NULL
its	NULL
electrophoretic	NULL
mobility	NULL
,	NULL
presumably	NULL
resulting	NULL
from	NULL
the	NULL
stabilization	NULL
of	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
the	NULL
IxBa	NULL
molecule	NULL
after	NULL
pretreatment	NULL
with	NULL
ALLN	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
no	NULL
change	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
the	NULL
murine	NULL
IxBa	NULL
protein	NULL
was	NULL
seen	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
although	NULL
this	NULL
protein	NULL
is	NULL
normally	NULL
degraded	NULL
following	NULL
stimula-tion	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
2D	NULL
gel	NULL
analysis	NULL
shows	NULL
a	NULL
shift	NULL
of	NULL
the	NULL
isoforms	NULL
of	NULL
the	NULL
murine	NULL
protein	NULL
towards	NULL
the	NULL
acidic	NULL
region	NULL
following	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
fact	NULL
that	NULL
murine	NULL
IxBa	NULL
is	NULL
also	NULL
hyperphosphorylated	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Treatment	NULL
of	NULL
resting	NULL
cells	NULL
with	NULL
ALLN	NULL
has	NULL
no	NULL
effect	NULL
upon	NULL
the	NULL
mobility	NULL
of	NULL
either	NULL
protein	NULL
during	NULL
SDS-PAGE	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
have	NULL
stably	NULL
transfected	NULL
various	NULL
mutant	NULL
human	NULL
IxBa	NULL
constructs	NULL
in	NULL
order	NULL
to	NULL
localize	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
protein	NULL
responsible	NULL
for	NULL
its	NULL
inducible	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
.	NULL

Deletion	NULL
of	NULL
IxBa	NULL
PEST	NULL
sequences	NULL
abolishes	NULL
degradation	NULL
and	NULL
constitutive	NULL
,	NULL
but	NULL
not	NULL
ligand-induced	NULL
,	NULL
phosphorylation	NULL
.	NULL

The	NULL
carboxy	NULL
terminus	NULL
of	NULL
IxBa	NULL
contains	NULL
PEST	NULL
sequences	NULL
,	NULL
which	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
function	NULL
as	NULL
instability	NULL
determinants	NULL
for	NULL
proteins	NULL
degraded	NULL
by	NULL
the	NULL
ubiquitin-268	NULL
proteasome	NULL
pathway	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Since	NULL
IxBa	NULL
degradation	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
sensitive	NULL
to	NULL
inhibitors	NULL
of	NULL
proteasome	NULL
activity	NULL
,	NULL
we	NULL
first	NULL
investigated	NULL
whether	NULL
this	NULL
region	NULL
of	NULL
the	NULL
protein	NULL
was	NULL
important	NULL
for	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
.	NULL

We	NULL
constructed	NULL
a	NULL
series	NULL
of	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
and	NULL
stably	NULL
transfected	NULL
them	NULL
into	NULL
70Z	NULL
,	NULL
/3	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
deletion	NULL
up	NULL
to	NULL
and	NULL
including	NULL
amino	NULL
acid	NULL
269	NULL
(	NULL
mutant	NULL
A268C	NULL
)	NULL
,	NULL
which	NULL
eliminates	NULL
most	NULL
of	NULL
the	NULL
PEST	NULL
sequences	NULL
,	NULL
abolished	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
transfected	NULL
protein	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
or	NULL
LPS	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
in	NULL
pulse	NULL
REGULATION	NULL
OF	NULL
IxBa	NULL
DEGRADATION	NULL
5341	NULL
chase	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
truncated	NULL
protein	NULL
is	NULL
still	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
retain	NULL
cotransfected	NULL
RelA	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
293	NULL
or	NULL
COS	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
extracts	NULL
pretreated	NULL
with	NULL
ALLN	NULL
before	NULL
PMA	NULL
or	NULL
LPS	NULL
stimulation	NULL
,	NULL
the	NULL
transfected	NULL
protein	NULL
was	NULL
subject	NULL
to	NULL
a	NULL
retardation	NULL
in	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
could	NULL
still	NULL
be	NULL
inducibly	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
external	NULL
signalling	NULL
.	NULL

Longer	NULL
exposure	NULL
of	NULL
the	NULL
filter	NULL
reveals	NULL
that	NULL
this	NULL
upshifted	NULL
band	NULL
is	NULL
also	NULL
present	NULL
when	NULL
cells	NULL
are	NULL
induced	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ALLN	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
Y-251	NULL
to	NULL
an	NULL
aspartic	NULL
acid	NULL
,	NULL
or	NULL
the	NULL
mutation	NULL
of	NULL
S-252	NULL
,	NULL
$	NULL
-262	NULL
,	NULL
or	NULL
T-263	NULL
to	NULL
an	NULL
alanine	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
either	NULL
phosphorylation	NULL
or	NULL
degradation	NULL
in	NULL
response	NULL
to	NULL
induction	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
these	NULL
are	NULL
phosphorylatable	NULL
residues	NULL
located	NULL
between	NULL
the	NULL
end	NULL
of	NULL
the	NULL
ankyrin	NULL
repeats	NULL
and	NULL
amino	NULL
acid	NULL
268	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
phosphorylation	NULL
sites	NULL
lie	NULL
elsewhere	NULL
in	NULL
the	NULL
molecule	NULL
.	NULL

The	NULL
deletion	NULL
of	NULL
sequences	NULL
up	NULL
to	NULL
and	NULL
including	NULL
amino	NULL
acid	NULL
279	NULL
(	NULL
A278C	NULL
)	NULL
also	NULL
stabilizes	NULL
the	NULL
protein	NULL
against	NULL
ligand-induced	NULL
degradation	NULL
,	NULL
while	NULL
a	NULL
protein	NULL
deleted	NULL
up	NULL
to	NULL
amino	NULL
acid	NULL
291	NULL
(	NULL
A290C	NULL
)	NULL
behaves	NULL
as	NULL
the	NULL
WT	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
amino	NULL
acids	NULL
279	NULL
to	NULL
290	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

While	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
full-length	NULL
proteins	NULL
exist	NULL
as	NULL
multiple	NULL
isoforms	NULL
in	NULL
uninduced	NULL
cells	NULL
as	NULL
revealed	NULL
by	NULL
multiple	NULL
spots	NULL
following	NULL
2D	NULL
gel	NULL
electrophoresis	NULL
and	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
(	NULL
mutant	NULL
A268C	NULL
)	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
single	NULL
spot	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
C-terminal	NULL
PEST	NULL
sequences	NULL
are	NULL
variably	NULL
phosphorylated	NULL
in	NULL
uninduced	NULL
cells	NULL
.	NULL

To	NULL
more	NULL
directly	NULL
demonstrate	NULL
that	NULL
constitutive	NULL
phosphorylation	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
PEST	NULL
region	NULL
of	NULL
the	NULL
molecule	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
immunoprecipitation	NULL
on	NULL
°°P	NULL
;	NULL
-labelled	NULL
cells	NULL
transfected	NULL
either	NULL
with	NULL
the	NULL
WT	NULL
human	NULL
IxBa	NULL
or	NULL
with	NULL
the	NULL
mutant	NULL
A268C	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
demonstrate	NULL
that	NULL
WT	NULL
human	NULL
IxBa	NULL
is	NULL
already	NULL
phosphorylated	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
that	NULL
treatment	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ALLN	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
additional	NULL
band	NULL
with	NULL
reduced	NULL
mobility	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
(	NULL
°°P	NULL
labelling	NULL
results	NULL
in	NULL
a	NULL
poor	NULL
resolution	NULL
of	NULL
the	NULL
two	NULL
bands	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
ECL	NULL
on	NULL
Western	NULL
blots	NULL
)	NULL
;	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
very	NULL
faint	NULL
band	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
A268C	NULL
mutant	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
;	NULL
clearly	NULL
visible	NULL
on	NULL
a	NULL
longer	NULL
exposure	NULL
)	NULL
,	NULL
while	NULL
LPS	NULL
treatment	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
electrophoretically	NULL
retarded	NULL
labelled	NULL
band	NULL
.	NULL

Western	NULL
blotting	NULL
of	NULL
controls	NULL
of	NULL
these	NULL
extracts	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
WT	NULL
and	NULL
A268C	NULL
proteins	NULL
in	NULL
unstimulated	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
the	NULL
upshifting	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
and	NULL
ALLN	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
almost	NULL
all	NULL
basal	NULL
phosphorylation	NULL
takes	NULL
place	NULL
between	NULL
amino	NULL
acids	NULL
269	NULL
and	NULL
317	NULL
and	NULL
that	NULL
inducible	NULL
phosphorylation	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
remaining	NULL
part	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

Since	NULL
the	NULL
mutations	NULL
of	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
to	NULL
alanines	NULL
in	NULL
the	NULL
PEST	NULL
region	NULL
have	NULL
only	NULL
slight	NULL
effects	NULL
upon	NULL
the	NULL
ability	NULL
of	NULL
IxBa	NULL
to	NULL
inhibit	NULL
DNA	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
10	NULL
)	NULL
and	NULL
have	NULL
no	NULL
effect	NULL
upon	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
function	NULL
of	NULL
these	NULL
constitutive	NULL
phosphorylations	NULL
of	NULL
IxBa	NULL
remains	NULL
,	NULL
for	NULL
the	NULL
moment	NULL
,	NULL
unclear	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
both	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
is	NULL
required	NULL
for	NULL
ligand-induced	NULL
degradation	NULL
of	NULL
transfected	NULL
IxBa	NULL
.	NULL

As	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
IxBa	NULL
had	NULL
no	NULL
effect	NULL
upon	NULL
its	NULL
ability	NULL
to	NULL
be	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
phosphorylatable	NULL
residues	NULL
in	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
first	NULL
30	NULL
amino	NULL
acids	NULL
of	NULL
IxBa	NULL
(	NULL
A30N	NULL
)	NULL
destabilized	NULL
the	NULL
protein	NULL
to	NULL
such	NULL
an	NULL
extent	NULL
that	NULL
it	NULL
was	NULL
not	NULL
visible	NULL
by	NULL
either	NULL
Western	NULL
blotting	NULL
or	NULL
immunoprecipitation	NULL
of	NULL
[	NULL
~S	NULL
]	NULL
methionine-labelled	NULL
extracts	NULL
from	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
this	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
IxBa	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
reveals	NULL
that	NULL
the	NULL
N	NULL
5342	NULL
WHITESIDE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
70Z/3	NULL
Emmer	NULL
m	NULL
G	NULL
``	NULL
``	NULL
``	NULL
#	NULL
#	NULL
s	NULL
hulxBoWT	NULL
m	NULL
B	NULL
(	NULL
hus	NULL
70Z/3	NULL
m	NULL
Q.	NULL
hulrBoA268C	NULL
m	NULL
~A	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Proteins	NULL
were	NULL
analyzed	NULL
by	NULL
2D	NULL
gel	NULL
electrophoresis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
murine	NULL
(	NULL
m	NULL
)	NULL
,	NULL
WT	NULL
human	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
truncated	NULL
human	NULL
(	NULL
A	NULL
)	NULL
IxBa	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
acidic	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
on	NULL
the	NULL
left	NULL
.	NULL

This	NULL
experiment	NULL
has	NULL
been	NULL
repeated	NULL
several	NULL
times	NULL
with	NULL
identical	NULL
results	NULL
.	NULL

(	NULL
A	NULL
)	NULL
70Z/3	NULL
,	NULL
70Z/3	NULL
cells	NULL
transfected	NULL
with	NULL
pRe-CMV	NULL
;	NULL
hul	NULL
«	NULL
kBaWT	NULL
,	NULL
702/3	NULL
cells	NULL
expressing	NULL
WT	NULL
human	NULL
IxBa	NULL
.	NULL

(	NULL
B	NULL
)	NULL
bhul	NULL
«	NULL
BaA268C	NULL
,	NULL
70Z	NULL
,	NULL
/3	NULL
cells	NULL
expressing	NULL
human	NULL
IxBoA268C	NULL
.	NULL

terminus	NULL
of	NULL
the	NULL
molecule	NULL
contains	NULL
two	NULL
highly	NULL
conserved	NULL
serine	NULL
or	NULL
threonine	NULL
residues	NULL
(	NULL
within	NULL
the	NULL
IxBa	NULL
or	NULL
IxBB	NULL
family	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
decided	NULL
to	NULL
mutate	NULL
these	NULL
residues	NULL
and	NULL
to	NULL
analyze	NULL
the	NULL
behavior	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
and	NULL
LPS	NULL
when	NULL
stably	NULL
expressed	NULL
in	NULL
70Z/3	NULL
cells	NULL
(	NULL
residue	NULL
62	NULL
,	NULL
which	NULL
in	NULL
the	NULL
human	NULL
protein	NULL
is	NULL
also	NULL
a	NULL
serine	NULL
,	NULL
is	NULL
not	NULL
conserved	NULL
in	NULL
murine	NULL
IxBa	NULL
and	NULL
therefore	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
further	NULL
;	NULL
mutation	NULL
of	NULL
threonine	NULL
at	NULL
position	NULL
71	NULL
to	NULL
an	NULL
alanine	NULL
results	NULL
in	NULL
a	NULL
molecule	NULL
with	NULL
a	NULL
greatly	NULL
reduced	NULL
affinity	NULL
for	NULL
the	NULL
Rel	NULL
proteins	NULL
and	NULL
a	NULL
very	NULL
short	NULL
half-life	NULL
,	NULL
thus	NULL
precluding	NULL
its	NULL
analysis	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
either	NULL
serine	NULL
32	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
D	NULL
)	NULL
or	NULL
serine	NULL
36	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
to	NULL
an	NULL
alanine	NULL
abolished	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
transfected	NULL
protein	NULL
following	NULL
stimulation	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
.	NULL

Since	NULL
the	NULL
mutation	NULL
of	NULL
serine	NULL
36	NULL
to	NULL
alanine	NULL
resulted	NULL
in	NULL
a	NULL
protein	NULL
(	NULL
S36A	NULL
)	NULL
with	NULL
an	NULL
altered	NULL
electrophoretic	NULL
migration	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
a	NULL
mutant	NULL
in	NULL
which	NULL
serine	NULL
36	NULL
was	NULL
changed	NULL
to	NULL
a	NULL
proline	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
also	NULL
not	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

These	NULL
two	NULL
mutant	NULL
proteins	NULL
also	NULL
undergo	NULL
electrophoretic	NULL
retardation	NULL
during	NULL
SDS-PAGE	NULL
when	NULL
extracts	NULL
are	NULL
prepared	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ALLN	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

The	NULL
extents	NULL
of	NULL
retardation	NULL
for	NULL
the	NULL
mutant	NULL
proteins	NULL
were	NULL
somewhat	NULL
less	NULL
than	NULL
that	NULL
of	NULL
the	NULL
WT	NULL
protein	NULL
,	NULL
but	NULL
this	NULL
could	NULL
be	NULL
due	NULL
to	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
-	NULL
1	NULL
=	NULL
2	NULL
-	NULL
hu-wt*	NULL
u-wit	NULL
___	NULL
tew	NULL
asr	NULL
wan	NULL
hund	NULL
'	NULL
wut	NULL
=-	NULL
tie	NULL
SP	NULL
ame	NULL
-	NULL
>	NULL
)	NULL
__	NULL
arse	NULL
Ares	NULL
-	NULL
|-	NULL
WB	NULL
‘	NULL
``	NULL
~-	NULL
AreBC	NULL
-	NULL
A268C	NULL
102	NULL
30	NULL
4	NULL
102	NULL
3	NULL
4	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

70Z/3	NULL
cells	NULL
transfected	NULL
with	NULL
WT	NULL
human	NULL
IxBa	NULL
or	NULL
with	NULL
the	NULL
A268C	NULL
mutant	NULL
were	NULL
starved	NULL
for	NULL
1	NULL
h	NULL
in	NULL
phosphate-free	NULL
medium	NULL
supplemented	NULL
with	NULL
3	NULL
%	NULL
dialyzed	NULL
calf	NULL
serum	NULL
and	NULL
then	NULL
were	NULL
labelled	NULL
for	NULL
3	NULL
h	NULL
with	NULL
0.5	NULL
mCi	NULL
of	NULL
*°P	NULL
;	NULL
per	NULL
ml	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
wM	NULL
ALLN	NULL
.	NULL

Half	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
labelling	NULL
period	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
then	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Aliquots	NULL
of	NULL
the	NULL
stimulated	NULL
or	NULL
unstimulated	NULL
cells	NULL
were	NULL
left	NULL
unlabelled	NULL
,	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
S7	NULL
antiserum	NULL
raised	NULL
against	NULL
recombinant	NULL
human	NULL
IxBa	NULL
(	NULL
essentially	NULL
identical	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
subjecting	NULL
the	NULL
labelled	NULL
extracts	NULL
to	NULL
precipitation	NULL
with	NULL
antiserum	NULL
1309	NULL
followed	NULL
by	NULL
immunoblot-ting	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
human	NULL
WT	NULL
IxBa	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
A268C	NULL
.	NULL

mu	NULL
,	NULL
endogenous	NULL
murine	NULL
IxBa	NULL
.	NULL

(	NULL
B	NULL
)	NULL
*°P-labelled	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
48068	NULL
raised	NULL
against	NULL
recombinant	NULL
human	NULL
IxBa	NULL
(	NULL
the	NULL
amounts	NULL
of	NULL
extract	NULL
were	NULL
adjusted	NULL
to	NULL
contain	NULL
approximately	NULL
identical	NULL
amounts	NULL
of	NULL
WT	NULL
or	NULL
A268C	NULL
proteins	NULL
,	NULL
as	NULL
determined	NULL
from	NULL
the	NULL
immunoblot	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
)	NULL
.	NULL

Following	NULL
boiling	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
a	NULL
second	NULL
immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
,	NULL
with	NULL
serum	NULL
1309	NULL
(	NULL
which	NULL
does	NULL
not	NULL
recognize	NULL
the	NULL
murine	NULL
molecule	NULL
)	NULL
raised	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
human	NULL
IxBa	NULL
,	NULL
and	NULL
then	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
analysis	NULL
on	NULL
a	NULL
12	NULL
%	NULL
SDS	NULL
gel	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
A268C	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
WT	NULL
human	NULL
IxBa	NULL
.	NULL

Asterisks	NULL
indicate	NULL
the	NULL
hyperphosphorylated	NULL
forms	NULL
of	NULL
the	NULL
given	NULL
molecules	NULL
.	NULL

differences	NULL
in	NULL
conformation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
mutant	NULL
proteins	NULL
can	NULL
be	NULL
partially	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
but	NULL
that	NULL
phosphorylation	NULL
at	NULL
both	NULL
serine	NULL
32	NULL
and	NULL
serine	NULL
36	NULL
is	NULL
required	NULL
for	NULL
the	NULL
protein	NULL
to	NULL
be	NULL
degraded	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
mutant	NULL
which	NULL
encodes	NULL
a	NULL
protein	NULL
in	NULL
which	NULL
both	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
are	NULL
changed	NULL
to	NULL
ala-nines	NULL
.	NULL

This	NULL
protein	NULL
,	NULL
when	NULL
stably	NULL
transfected	NULL
into	NULL
70Z/3	NULL
cells	NULL
,	NULL
was	NULL
also	NULL
not	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
protein	NULL
did	NULL
not	NULL
undergo	NULL
any	NULL
change	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
ALLN	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
,	NULL
last	NULL
lane	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
complete	NULL
absence	NULL
of	NULL
ligand-induced	NULL
phosphorylation	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
transfected	NULL
human	NULL
IxBa	NULL
was	NULL
somehow	NULL
variable	NULL
depending	NULL
on	NULL
the	NULL
mutant	NULL
considered	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
this	NULL
was	NULL
an	NULL
indication	NULL
of	NULL
a	NULL
different	NULL
stability	NULL
of	NULL
these	NULL
mutants	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
half-lives	NULL
of	NULL
these	NULL
molecules	NULL
by	NULL
pulse-chase	NULL
experiments	NULL
in	NULL
untreated	NULL
cells	NULL
and	NULL
found	NULL
that	NULL
the	NULL
half-lives	NULL
of	NULL
WT	NULL
human	NULL
and	NULL
endogenous	NULL
murine	NULL
IxBa	NULL
were	NULL
about	NULL
45	NULL
min	NULL
,	NULL
while	NULL
that	NULL
of	NULL
mutant	NULL
$	NULL
36A	NULL
was	NULL
more	NULL
than	NULL
60	NULL
min	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
a	NULL
given	NULL
mutant	NULL
protein	NULL
in	NULL
a	NULL
given	NULL
transfection	NULL
is	NULL
not	NULL
a	NULL
reflection	NULL
of	NULL
its	NULL
half-life	NULL
but	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
random	NULL
,	NULL
as	NULL
observed	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
several	NULL
transformation	NULL
experiments	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
obtain	NULL
more-direct	NULL
evidence	NULL
that	NULL
phosphorylation	NULL
takes	NULL
place	NULL
on	NULL
these	NULL
serines	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
our	NULL
observation	NULL
that	NULL
thrombin	NULL
cleaves	NULL
human	NULL
IxBa	NULL
after	NULL
amino	NULL
acid	NULL
61	NULL
(	NULL
at	NULL
the	NULL
sequence	NULL
PRGS	NULL
;	NULL
see	NULL
also	NULL
reference	NULL
12	NULL
)	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
an	NULL
N-terminal	NULL
fragment	NULL
containing	NULL
only	NULL
two	NULL
phosphorylatable	NULL
residues	NULL
,	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
(	NULL
there	NULL
is	NULL
also	NULL
a	NULL
Y	NULL
at	NULL
position	NULL
42	NULL
,	NULL
but	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
anti-phosphoty-rosine	NULL
antiserum	NULL
indicated	NULL
that	NULL
IxBa	NULL
is	NULL
not	NULL
phosphorylated	NULL
on	NULL
tyrosines	NULL
following	NULL
treatment	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
of	NULL
70Z/3	NULL
clones	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ALLN	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
first	NULL
with	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
human	NULL
IxBa	NULL
.	NULL

Digestion	NULL
with	NULL
thrombin	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
the	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
,	NULL
therefore	NULL
releasing	NULL
the	NULL
N-terminal	NULL
61	NULL
amino	NULL
acids	NULL
of	NULL
this	NULL
molecule	NULL
into	NULL
the	NULL
supernatant	NULL
.	NULL

This	NULL
supernatant	NULL
was	NULL
run	NULL
on	NULL
a	NULL
Tricine	NULL
gel	NULL
(	NULL
allowing	NULL
resolution	NULL
of	NULL
small	NULL
peptides	NULL
)	NULL
,	NULL
which	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
Immobilon	NULL
mem-	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
REGULATION	NULL
OF	NULL
IxBa	NULL
DEGRADATION	NULL
5343	NULL
A	NULL
B	NULL
wT	NULL
--	NULL
gous	NULL
--	NULL
s2a	NULL
s6P	NULL
C	NULL
m	NULL
--	NULL
A	NULL
--	NULL
--	NULL
-m	NULL
--	NULL
--	NULL
-4	NULL
WT	NULL
36A	NULL
WT	NULL
36A	NULL
FOP	NULL
-	NULL
Fp	NULL
--	NULL
I	NULL
mouse	NULL
IxBa	NULL
27	NULL
DDRHDSGLDSMKDEEY	NULL
0	NULL
4	NULL
-	NULL
0	NULL
40	NULL
.	NULL

0	NULL
po-	NULL
0	NULL
4	NULL
.	NULL

-	NULL
PMA	NULL
0	NULL
o-	NULL
%	NULL
0	NULL
-	NULL
£	NULL
0	NULL
-	NULL
£	NULL
0	NULL
-	NULL
£0	NULL
LPs	NULL
human	NULL
IxBa	NULL
27	NULL
DDRHDSGLDSMKDEEY	NULL
BU	NULL
.as	NULL
he	NULL
wan	NULL
ame	NULL
=~	NULL
rat	NULL
IxBa	NULL
27	NULL
DDRHDSGLDSMKDEDY	NULL
mu	NULL
w	NULL
-	NULL
ames	NULL
c	NULL
_	NULL
ame	NULL
ame	NULL
pig	NULL
IxBo	NULL
.	NULL

27	NULL
DDRHDSCLDSMKEEEY	NULL
chicken	NULL
IxBo	NULL
27	NULL
DDRHDSCGLDSMEKDEEY	NULL
anti-human	NULL
anti-murine	NULL
D	NULL
32A	NULL
s6P	NULL
r	NULL
WT	NULL
__	NULL
32A36A	NULL
T-	NULL
--	NULL
r	NULL
-	NULL
--	NULL
-4	NULL
murine	NULL
IBB	NULL
14	NULL
DEWCDSGLGSLGPDAA	NULL
m-	NULL
--	NULL
-	NULL
--	NULL
A	NULL
#	NULL
>	NULL
-	NULL
#	NULL
0	NULL
-	NULL
-	NULL
$	NULL
0	NULL
ALLN	NULL
non	NULL
#	NULL
-o-	NULL
+	NULL
.	NULL

ALIN	NULL
human	NULL
IxBB	NULL
14	NULL
DEWCDTGLGSLGPDAA	NULL
0	NULL
L	NULL
L	NULL
0	NULL
L	NULL
L	NULL
0	NULL
L	NULL
Loo	NULL
IPs	NULL
o	NULL
LOL	NULL
0	NULL
LoL	NULL
m	NULL
Oke	NULL
zy	NULL
z	NULL
es	NULL
mu	NULL
~~~	NULL
z	NULL
>	NULL
hu	NULL
__	NULL
sme	NULL
--	NULL
hu*	NULL
mu	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Amino	NULL
acid	NULL
sequences	NULL
of	NULL
IxBa	NULL
proteins	NULL
showing	NULL
homology	NULL
around	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
(	NULL
shown	NULL
in	NULL
boldface	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
sequences	NULL
of	NULL
murine	NULL
(	NULL
34	NULL
)	NULL
and	NULL
human	NULL
(	NULL
16	NULL
)	NULL
IxBB	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
70Z/3	NULL
cells	NULL
(	NULL
15	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
metabolically	NULL
labelled	NULL
for	NULL
2	NULL
h	NULL
with	NULL
and	NULL
then	NULL
were	NULL
diluted	NULL
in	NULL
prewarmed	NULL
,	NULL
complete	NULL
medium	NULL
containing	NULL
50	NULL
mM	NULL
-cysteine-t-methionine	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
either	NULL
lysed	NULL
directly	NULL
(	NULL
0	NULL
)	NULL
or	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
before	NULL
lysis	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.05	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
)	NULL
,	NULL
and	NULL
after	NULL
centrifugation	NULL
for	NULL
2	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
,	NULL
supernatants	NULL
were	NULL
transferred	NULL
to	NULL
new	NULL
tubes	NULL
.	NULL

SDS	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
%	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
boiled	NULL
before	NULL
dilution	NULL
in	NULL
RIPA	NULL
buffer	NULL
.	NULL

After	NULL
preclearing	NULL
overnight	NULL
with	NULL
a	NULL
preimmune	NULL
serum	NULL
,	NULL
IxBa	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
anti-IxBaN	NULL
(	NULL
1309	NULL
)	NULL
,	NULL
anti-IxBaC	NULL
(	NULL
296	NULL
)	NULL
,	NULL
and	NULL
anti-rat	NULL
IxBa	NULL
(	NULL
32	NULL
)	NULL
antisera	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
expressing	NULL
the	NULL
following	NULL
:	NULL
WT	NULL
,	NULL
human	NULL
IxBa	NULL
WT	NULL
protein	NULL
;	NULL
702/3	NULL
,	NULL
70Z/3	NULL
cells	NULL
transformed	NULL
with	NULL
the	NULL
Re-CMV	NULL
vector	NULL
alone	NULL
;	NULL
32A	NULL
,	NULL
human	NULL
IxBa	NULL
protein	NULL
containing	NULL
the	NULL
mutation	NULL
serine	NULL
32	NULL
to	NULL
alanine	NULL
;	NULL
36P	NULL
,	NULL
human	NULL
IxB	NULL
«	NULL
protein	NULL
containing	NULL
the	NULL
mutation	NULL
serine	NULL
36	NULL
to	NULL
proline	NULL
.	NULL

(	NULL
C	NULL
)	NULL
70Z/3	NULL
cells	NULL
expressing	NULL
WT	NULL
IxBa	NULL
protein	NULL
or	NULL
the	NULL
mutant	NULL
protein	NULL
carrying	NULL
the	NULL
mutation	NULL
serine	NULL
36	NULL
to	NULL
alanine	NULL
(	NULL
36A	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
20	NULL
pg	NULL
of	NULL
cycloheximide	NULL
per	NULL
ml	NULL
(	NULL
-	NULL
)	NULL
or	NULL
20	NULL
ug	NULL
of	NULL
cycloheximide	NULL
per	NULL
ml	NULL
plus	NULL
20	NULL
pg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
(	NULL
+	NULL
)	NULL
or	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
lysed	NULL
in	NULL
SDS-PAGE	NULL
loading	NULL
buffer	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
duplicate	NULL
gels	NULL
.	NULL

After	NULL
blotting	NULL
,	NULL
filters	NULL
were	NULL
probed	NULL
with	NULL
anti-human	NULL
IxBa	NULL
«	NULL
antiserum	NULL
(	NULL
1309	NULL
;	NULL
left	NULL
panel	NULL
)	NULL
,	NULL
to	NULL
detect	NULL
only	NULL
the	NULL
transfected	NULL
molecule	NULL
,	NULL
or	NULL
anti-murine	NULL
antiserum	NULL
(	NULL
751	NULL
;	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
to	NULL
detect	NULL
the	NULL
endogenous	NULL
murine	NULL
molecule	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Cells	NULL
expressing	NULL
WT	NULL
or	NULL
mutant	NULL
(	NULL
32A	NULL
or	NULL
36P	NULL
)	NULL
human	NULL
IxBa	NULL
proteins	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
then	NULL
were	NULL
pelleted	NULL
,	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
ALLN	NULL
(	NULL
100	NULL
M	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
,	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
S7	NULL
anti-IxBa	NULL
antiserum	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
murine	NULL
(	NULL
mu	NULL
)	NULL
,	NULL
human	NULL
(	NULL
bu	NULL
)	NULL
,	NULL
and	NULL
electrophoretically	NULL
retarded	NULL
human	NULL
(	NULL
bu*	NULL
)	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Cells	NULL
expressing	NULL
WT	NULL
or	NULL
mutant	NULL
human	NULL
IxBa	NULL
protein	NULL
containing	NULL
the	NULL
double	NULL
mutation	NULL
of	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
to	NULL
alanines	NULL
(	NULL
32A36A	NULL
)	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
and	NULL
then	NULL
were	NULL
pelleted	NULL
,	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
ALLN	NULL
(	NULL
100	NULL
M	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
,	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

4D	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
murine	NULL
(	NULL
mu	NULL
)	NULL
,	NULL
human	NULL
(	NULL
hu	NULL
)	NULL
,	NULL
and	NULL
electrophoretically	NULL
retarded	NULL
human	NULL
(	NULL
hu*	NULL
)	NULL
proteins	NULL
are	NULL
indicated	NULL
.	NULL

branes	NULL
and	NULL
blotted	NULL
with	NULL
antiserum	NULL
1309	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
IxBa	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
additional	NULL
band	NULL
,	NULL
with	NULL
slower	NULL
mobilities	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
the	NULL
WT	NULL
human	NULL
molecule	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
S36P	NULL
mutant	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
with	NULL
slower	NULL
mobility	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
double	NULL
mutant	NULL
S32A	NULL
,	NULL
$	NULL
36A	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
thrombin	NULL
supernatant	NULL
of	NULL
the	NULL
WT	NULL
molecule	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
wt	NULL
S36P	NULL
S32A,536A	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
--	NULL
25	NULL
--	NULL
16.5	NULL
-	NULL
6.5	NULL
LPS/ALLN	NULL
#	NULL
0	NULL
goog	NULL
o-	NULL
$	NULL
o	NULL
-	NULL
+	NULL
AP	NULL
+	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
of	NULL
70Z/3	NULL
clones	NULL
transfected	NULL
with	NULL
either	NULL
WT	NULL
human	NULL
IxBa	NULL
or	NULL
with	NULL
mutants	NULL
S36P	NULL
or	NULL
$	NULL
32A,836A	NULL
,	NULL
either	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
10	NULL
jg	NULL
of	NULL
LPS	NULL
for	NULL
45	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
M	NULL
ALLN	NULL
(	NULL
+	NULL
)	NULL
as	NULL
indicated	NULL
,	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
antiserum	NULL
296	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

The	NULL
immunoprecipitate	NULL
was	NULL
digested	NULL
with	NULL
thrombin	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
the	NULL
released	NULL
N-terminal	NULL
61-amino-acid	NULL
peptide	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
16.5	NULL
%	NULL
Tricine	NULL
gel	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
antiserum	NULL
1309	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
human	NULL
IxBe	NULL
.	NULL

In	NULL
lane	NULL
3	NULL
,	NULL
the	NULL
peptide	NULL
was	NULL
treated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
AP	NULL
)	NULL
before	NULL
analysis	NULL
on	NULL
the	NULL
Tricine	NULL
gel	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
on	NULL
the	NULL
right	NULL
.	NULL

results	NULL
in	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
upshifted	NULL
band	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
is	NULL
due	NULL
to	NULL
phosphorylation	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
induced	NULL
phosphorylation	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
first	NULL
61	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
molecule	NULL
,	NULL
that	NULL
is	NULL
,	NULL
on	NULL
serine	NULL
32	NULL
or	NULL
36	NULL
or	NULL
both	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
stabilities	NULL
of	NULL
these	NULL
mutants	NULL
were	NULL
not	NULL
the	NULL
result	NULL
of	NULL
a	NULL
loss	NULL
of	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
Rel-family	NULL
proteins	NULL
,	NULL
we	NULL
tested	NULL
their	NULL
abilities	NULL
to	NULL
interact	NULL
with	NULL
either	NULL
c-Rel	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
or	NULL
RelA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
serine	NULL
32	NULL
or	NULL
36	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
for	NULL
c-Rel	NULL
.	NULL

The	NULL
double	NULL
mutant	NULL
of	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
to	NULL
alanines	NULL
bound	NULL
both	NULL
c-Rel	NULL
and	NULL
RelA	NULL
,	NULL
with	NULL
affinities	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
WT	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vivo	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
following	NULL
stimulation	NULL
,	NULL
a	NULL
process	NULL
thought	NULL
to	NULL
take	NULL
place	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/IxB	NULL
complex	NULL
following	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
IxBa	NULL
molecule	NULL
(	NULL
1	NULL
,	NULL
9	NULL
,	NULL
18	NULL
,	NULL
21	NULL
,	NULL
23	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimulation	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
C	NULL
terminus	NULL
as	NULL
well	NULL
as	NULL
the	NULL
phosphorylation	NULL
of	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
broad	NULL
agreement	NULL
with	NULL
recently	NULL
published	NULL
data	NULL
(	NULL
6	NULL
)	NULL
,	NULL
with	NULL
one	NULL
important	NULL
difference	NULL
:	NULL
in	NULL
our	NULL
cell	NULL
line	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
mutate	NULL
both	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
to	NULL
abolish	NULL
ligand-inducible	NULL
phosphorylation	NULL
,	NULL
whereas	NULL
according	NULL
to	NULL
the	NULL
published	NULL
data	NULL
,	NULL
mutation	NULL
of	NULL
one	NULL
serine	NULL
or	NULL
the	NULL
other	NULL
was	NULL
sufficient	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
discrepancy	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
two	NULL
reports	NULL
demon	NULL
5344	NULL
WHITESIDE	NULL
ET	NULL
AL	NULL
.	NULL

WT	NULL
36P	NULL
62A	NULL
Rel	NULL
32A	NULL
36A	NULL
Mock	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Lysates	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
either	NULL
with	NULL
WT	NULL
human	NULL
IxBa	NULL
or	NULL
with	NULL
human	NULL
IxBa	NULL
containing	NULL
the	NULL
mutation	NULL
Ser-32	NULL
to	NULL
Ala	NULL
(	NULL
Ser-32-Ala	NULL
)	NULL
(	NULL
32A	NULL
)	NULL
,	NULL
Ser-36-Pro	NULL
(	NULL
36P	NULL
)	NULL
,	NULL
Ser-36-Ala	NULL
(	NULL
36A	NULL
)	NULL
,	NULL
or	NULL
Ser-62-Ala	NULL
(	NULL
62A	NULL
)	NULL
or	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
(	NULL
Mock	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
lysates	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
c-Rel	NULL
and	NULL
were	NULL
metabolically	NULL
labelled	NULL
with	NULL
1.-	NULL
[	NULL
*°S	NULL
)	NULL
methionine-.-	NULL
[	NULL
*S	NULL
Jcysteine	NULL
and	NULL
precipitated	NULL
with	NULL
anti-IxBaN	NULL
antiserum	NULL
(	NULL
1309	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
a	NULL
sample	NULL
of	NULL
the	NULL
labelled	NULL
lysate	NULL
was	NULL
precipitated	NULL
with	NULL
anti-c-Rel	NULL
(	NULL
Rel	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
;	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
band	NULL
comigrating	NULL
with	NULL
that	NULL
of	NULL
the	NULL
positive	NULL
control	NULL
indicates	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
given	NULL
mutant	NULL
of	NULL
IxBa	NULL
to	NULL
interact	NULL
with	NULL
c-Rel	NULL
.	NULL

strated	NULL
the	NULL
importance	NULL
of	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
for	NULL
the	NULL
induced	NULL
degradation	NULL
of	NULL
the	NULL
IxBa	NULL
molecule	NULL
(	NULL
5	NULL
,	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
reports	NULL
directly	NULL
demonstrates	NULL
that	NULL
phosphorylation	NULL
takes	NULL
place	NULL
on	NULL
these	NULL
two	NULL
serines	NULL
.	NULL

One	NULL
question	NULL
that	NULL
remains	NULL
unanswered	NULL
is	NULL
whether	NULL
in	NULL
vivo	NULL
phosphorylation	NULL
takes	NULL
place	NULL
on	NULL
both	NULL
serines	NULL
or	NULL
on	NULL
one	NULL
of	NULL
them	NULL
only	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
only	NULL
one	NULL
serine	NULL
abolishes	NULL
degradation	NULL
but	NULL
not	NULL
phosphorylation	NULL
on	NULL
the	NULL
other	NULL
serine	NULL
would	NULL
tend	NULL
to	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
on	NULL
both	NULL
serines	NULL
is	NULL
required	NULL
;	NULL
however	NULL
,	NULL
direct	NULL
sequencing	NULL
or	NULL
mass	NULL
spectrometry	NULL
analysis	NULL
of	NULL
the	NULL
phosphorylated	NULL
peptide	NULL
isolated	NULL
from	NULL
stimulated	NULL
cells	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
answer	NULL
this	NULL
question	NULL
.	NULL

The	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
is	NULL
rich	NULL
in	NULL
the	NULL
amino	NULL
acids	NULL
P	NULL
,	NULL
E	NULL
,	NULL
D	NULL
,	NULL
S	NULL
,	NULL
and	NULL
T	NULL
,	NULL
and	NULL
such	NULL
PEST	NULL
sequences	NULL
have	NULL
been	NULL
correlated	NULL
with	NULL
high	NULL
rates	NULL
of	NULL
protein	NULL
turnover	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
amino	NULL
acids	NULL
279	NULL
and	NULL
290	NULL
are	NULL
critical	NULL
for	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
,	NULL
results	NULL
that	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
a	NULL
recently	NULL
published	NULL
paper	NULL
(	NULL
28	NULL
)	NULL
.	NULL

This	NULL
region	NULL
of	NULL
the	NULL
molecule	NULL
contains	NULL
75	NULL
%	NULL
(	NULL
9	NULL
of	NULL
12	NULL
)	NULL
PEST	NULL
residues	NULL
,	NULL
indicating	NULL
an	NULL
important	NULL
role	NULL
for	NULL
such	NULL
sequences	NULL
in	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

2D	NULL
gel	NULL
electrophoresis	NULL
and	NULL
°°P	NULL
labelling	NULL
analyses	NULL
comparing	NULL
the	NULL
WT	NULL
molecule	NULL
with	NULL
a	NULL
mutant	NULL
lacking	NULL
the	NULL
PEST	NULL
domain	NULL
suggest	NULL
that	NULL
this	NULL
C-terminal	NULL
region	NULL
is	NULL
multiply	NULL
and	NULL
variably	NULL
phosphorylated	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

One	NULL
alternative	NULL
interpretation	NULL
of	NULL
our	NULL
results	NULL
,	NULL
although	NULL
less	NULL
likely	NULL
,	NULL
is	NULL
that	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
in	NULL
the	NULL
A268C	NULL
mutant	NULL
removes	NULL
regulatory	NULL
determinants	NULL
that	NULL
mediate	NULL
distal	NULL
phosphorylation	NULL
events	NULL
.	NULL

Since	NULL
the	NULL
mutation	NULL
of	NULL
serines	NULL
and	NULL
threonines	NULL
in	NULL
this	NULL
region	NULL
has	NULL
no	NULL
effect	NULL
upon	NULL
protein	NULL
stability	NULL
following	NULL
induction	NULL
,	NULL
the	NULL
role	NULL
of	NULL
these	NULL
phosphorylations	NULL
remains	NULL
unclear	NULL
.	NULL

It	NULL
may	NULL
be	NULL
that	NULL
the	NULL
C	NULL
terminus	NULL
acts	NULL
to	NULL
correctly	NULL
position	NULL
the	NULL
IxBa	NULL
molecule	NULL
upon	NULL
the	NULL
NF-kB	NULL
complex	NULL
so	NULL
that	NULL
it	NULL
can	NULL
be	NULL
recognized	NULL
by	NULL
the	NULL
degradation	NULL
machinery	NULL
following	NULL
phosphorylation	NULL
upon	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
IxBa	NULL
molecule	NULL
is	NULL
phosphorylated	NULL
by	NULL
a	NULL
kinase	NULL
(	NULL
or	NULL
kinases	NULL
)	NULL
which	NULL
phosphorylates	NULL
residues	NULL
32	NULL
and	NULL
36	NULL
.	NULL

Upon	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
inducers	NULL
of	NULL
NF-kB	NULL
,	NULL
this	NULL
activity	NULL
is	NULL
upregulated	NULL
and	NULL
the	NULL
increased	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
targets	NULL
the	NULL
protein	NULL
for	NULL
rapid	NULL
degradation	NULL
.	NULL

This	NULL
activation	NULL
could	NULL
result	NULL
from	NULL
a	NULL
direct	NULL
increase	NULL
in	NULL
kinase	NULL
activity	NULL
,	NULL
or	NULL
alternatively	NULL
,	NULL
it	NULL
could	NULL
be	NULL
that	NULL
the	NULL
kinase	NULL
activity	NULL
is	NULL
constitutive	NULL
and	NULL
that	NULL
in	NULL
uninduced	NULL
cells	NULL
there	NULL
exists	NULL
a	NULL
highly	NULL
active	NULL
phosphatase	NULL
which	NULL
removes	NULL
the	NULL
phosphate	NULL
groups	NULL
from	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
.	NULL

Upon	NULL
induction	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
phosphatase	NULL
would	NULL
be	NULL
sharply	NULL
downregulated	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
hyperphos-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

phorylated	NULL
form	NULL
of	NULL
IxBa	NULL
which	NULL
is	NULL
then	NULL
degraded	NULL
.	NULL

Such	NULL
a	NULL
hypothesis	NULL
might	NULL
explain	NULL
how	NULL
NF-B	NULL
is	NULL
activated	NULL
by	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
the	NULL
phosphatase	NULL
inhibitor	NULL
okadaic	NULL
acid	NULL
(	NULL
see	NULL
reference	NULL
36	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
N-terminal	NULL
sequences	NULL
for	NULL
known	NULL
kinase	NULL
sites	NULL
reveals	NULL
that	NULL
serines	NULL
at	NULL
positions	NULL
32	NULL
and	NULL
36	NULL
each	NULL
lie	NULL
within	NULL
a	NULL
consensus	NULL
casein	NULL
kinase	NULL
II	NULL
(	NULL
CKII	NULL
)	NULL
site	NULL
.	NULL

It	NULL
must	NULL
also	NULL
be	NULL
noted	NULL
that	NULL
these	NULL
residues	NULL
do	NULL
not	NULL
form	NULL
a	NULL
site	NULL
for	NULL
the	NULL
double-stranded	NULL
RNA-induced	NULL
kinase	NULL
protein	NULL
kinase	NULL
R	NULL
(	NULL
PKR	NULL
)	NULL
,	NULL
an	NULL
enzyme	NULL
which	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
required	NULL
for	NULL
NF-kB	NULL
activation	NULL
by	NULL
double-stranded	NULL
RNA	NULL
and	NULL
viruses	NULL
(	NULL
14	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
IxBB	NULL
,	NULL
the	NULL
second	NULL
major	NULL
isoform	NULL
of	NULL
IxB	NULL
found	NULL
in	NULL
cells	NULL
,	NULL
also	NULL
contains	NULL
two	NULL
serines	NULL
(	NULL
or	NULL
one	NULL
serine	NULL
and	NULL
one	NULL
threonine	NULL
for	NULL
the	NULL
human	NULL
molecule	NULL
)	NULL
separated	NULL
by	NULL
3	NULL
amino	NULL
acids	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
whose	NULL
sequence	NULL
context	NULL
resembles	NULL
that	NULL
of	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
of	NULL
the	NULL
a	NULL
isoform	NULL
(	NULL
16	NULL
,	NULL
34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
IxBB	NULL
is	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
it	NULL
does	NULL
not	NULL
respond	NULL
to	NULL
PMA	NULL
.	NULL

Whether	NULL
these	NULL
residues	NULL
are	NULL
required	NULL
for	NULL
the	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBB	NULL
,	NULL
and	NULL
whether	NULL
the	NULL
same	NULL
activity	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
both	NULL
molecules	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

The	NULL
control	NULL
of	NULL
protein	NULL
degradation	NULL
by	NULL
means	NULL
of	NULL
phosphorylation	NULL
or	NULL
dephosphorylation	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
,	NULL
although	NULL
in	NULL
most	NULL
cases	NULL
the	NULL
sequences	NULL
responsible	NULL
have	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

Phosphorylation	NULL
of	NULL
microtubule-associated	NULL
protein	NULL
2	NULL
(	NULL
MAP-2	NULL
)	NULL
by	NULL
the	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
inhibits	NULL
calpain-induced	NULL
hydrolysis	NULL
of	NULL
MAP-2	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
stabilities	NULL
of	NULL
the	NULL
two	NULL
yeast	NULL
cyclin	NULL
inhibitor	NULL
proteins	NULL
Farl	NULL
and	NULL
Sic1	NULL
also	NULL
appear	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Sicl	NULL
is	NULL
degraded	NULL
in	NULL
a	NULL
ubiquitin-dependent	NULL
manner	NULL
,	NULL
possibly	NULL
as	NULL
a	NULL
result	NULL
of	NULL
phosphorylation	NULL
(	NULL
for	NULL
a	NULL
discussion	NULL
,	NULL
see	NULL
reference	NULL
30	NULL
)	NULL
.	NULL

The	NULL
manner	NULL
by	NULL
which	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
targets	NULL
the	NULL
molecule	NULL
for	NULL
degradation	NULL
is	NULL
unclear	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
both	NULL
N-	NULL
and	NULL
C-terminal	NULL
domains	NULL
play	NULL
roles	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
recombination	NULL
activator	NULL
protein	NULL
RAG-2	NULL
,	NULL
the	NULL
sequences	NULL
responsible	NULL
for	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
are	NULL
found	NULL
in	NULL
the	NULL
C-terminal	NULL
90	NULL
amino	NULL
acids	NULL
,	NULL
which	NULL
encode	NULL
a	NULL
threonine	NULL
(	NULL
T-490	NULL
)	NULL
as	NULL
well	NULL
as	NULL
a	NULL
lysine-rich	NULL
region	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Instability	NULL
is	NULL
determined	NULL
by	NULL
phosphorylation	NULL
of	NULL
threonine	NULL
490	NULL
.	NULL

Degradation	NULL
of	NULL
the	NULL
c-Mos	NULL
proto-oncogene	NULL
product	NULL
in	NULL
activated	NULL
Xenopus	NULL
eggs	NULL
requires	NULL
ubiquitination	NULL
of	NULL
lysine	NULL
residue	NULL
34	NULL
,	NULL
which	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
dephosphorylation	NULL
of	NULL
a	NULL
serine	NULL
residue	NULL
at	NULL
position	NULL
3	NULL
(	NULL
22	NULL
)	NULL
.	NULL

How	NULL
phosphorylation	NULL
and	NULL
dephosphorylation	NULL
act	NULL
to	NULL
induce	NULL
ubiquitin-dependent	NULL
protein	NULL
degradation	NULL
in	NULL
these	NULL
two	NULL
cases	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
recent	NULL
findings	NULL
that	NULL
p105	NULL
,	NULL
the	NULL
precursor	NULL
protein	NULL
for	NULL
the	NULL
50-kDa	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
requires	NULL
the	NULL
ubiquitin-268	NULL
proteasome	NULL
pathway	NULL
for	NULL
its	NULL
maturation	NULL
and	NULL
that	NULL
inhibitors	NULL
of	NULL
p105	NULL
maturation	NULL
also	NULL
inhibit	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
suggest	NULL
that	NULL
IxBa	NULL
is	NULL
also	NULL
degraded	NULL
by	NULL
this	NULL
pathway	NULL
(	NULL
23	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
data	NULL
show	NULL
that	NULL
phosphorylated	NULL
IxBa	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
ubiquitin-dependent	NULL
proteolytic	NULL
degradation	NULL
(	NULL
1a	NULL
)	NULL
.	NULL

We	NULL
note	NULL
the	NULL
presence	NULL
of	NULL
lysine	NULL
residues	NULL
at	NULL
positions	NULL
21	NULL
,	NULL
22	NULL
,	NULL
and	NULL
38	NULL
,	NULL
which	NULL
could	NULL
serve	NULL
as	NULL
sites	NULL
for	NULL
ubiquitin	NULL
binding	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
testing	NULL
the	NULL
functions	NULL
of	NULL
these	NULL
lysines	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
A.	NULL
C.	NULL
Lindon	NULL
for	NULL
continual	NULL
support	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
C.	NULL
Brou	NULL
and	NULL
M.-L.	NULL
MacKichan	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
M.-L.	NULL
MacKichan	NULL
for	NULL
her	NULL
advice	NULL
in	NULL
the	NULL
thrombin	NULL
experiments	NULL
,	NULL
Ron	NULL
Hay	NULL
(	NULL
St.	NULL
Andrews	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
anti-IxBa	NULL
«	NULL
antiserum	NULL
,	NULL
and	NULL
Gilles	NULL
Courtois	NULL
for	NULL
his	NULL
help	NULL
and	NULL
advice	NULL
in	NULL
the	NULL
transfection	NULL
of	NULL
cells	NULL
.	NULL

This	NULL
research	NULL
was	NULL
sponsored	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
ARC	NULL
,	NULL
ANRS	NULL
,	NULL
INSERM	NULL
,	NULL
and	NULL
the	NULL
Ligue	NULL
Nationale	NULL
Francaise	NULL
contre	NULL
le	NULL
Cancer	NULL
to	NULL
A.J	NULL
.	NULL

and	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
DHHS	NULL
,	NULL
contract	NULL
NO1-CO-46000	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
with	NULL
ABL-Basic	NULL
Research	NULL
Program	NULL
,	NULL
to	NULL
N.R	NULL
.	NULL

S.T.W	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
long-term	NULL
fellowship	NULL
LT-607/93	NULL
from	NULL
the	NULL
International	NULL
Human	NULL
Frontier	NULL
Science	NULL
Program	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alkalay	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Yaron	NULL
,	NULL
A.	NULL
Hatzubai	NULL
,	NULL
S.	NULL
Jung	NULL
,	NULL
A.	NULL
Avraham	NULL
,	NULL
O.	NULL
Gerlitz	NULL
,	NULL
I.	NULL
Pashut-Lavon	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vivo	NULL
stimulation	NULL
of	NULL
IB	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1294-1301.	NULL
la.Alkalay	NULL
,	NULL
I.	NULL
,	NULL
A.	NULL
Yaron	NULL
,	NULL
A.	NULL
Hatzubai	NULL
,	NULL
A.	NULL
Orian	NULL
,	NULL
A.	NULL
Ciechanover	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

2	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

3	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IxB	NULL
proteins-multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2064-2070	NULL
.	NULL

4	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

5	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809-2818	NULL
.	NULL

6	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxBa	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal	NULL
induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485-1488	NULL
.	NULL

7	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxBe	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

8	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysac-charide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-Rel	NULL
and	NULL
related	NULL
NF-xB	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:11803-11810	NULL
.	NULL

9	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBo	NULL
precedes	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1302-1311	NULL
.	NULL

10	NULL
.	NULL

Ernst	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
L.	NULL
L.	NULL
Dunn	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
PEST-like	NULL
sequence	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
responsible	NULL
for	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
but	NULL
not	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
c-Rel	NULL
or	NULL
RelA	NULL
homodimers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:872-882	NULL
.	NULL

11	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben	NULL
Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

12	NULL
.	NULL

Jaffray	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

1995	NULL
.	NULL

Domain	NULL
organization	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
sites	NULL
of	NULL
interaction	NULL
with	NULL
NF-kB	NULL
p65	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2166-2172	NULL
.	NULL

13	NULL
.	NULL

Johnson	NULL
,	NULL
G.	NULL
V.	NULL
,	NULL
and	NULL
V.	NULL
G.	NULL
Foley	NULL
.	NULL

1993	NULL
.	NULL

Calpain	NULL
mediated	NULL
proteolysis	NULL
of	NULL
microtubule	NULL
associated	NULL
protein	NULL
2	NULL
(	NULL
MAP-2	NULL
)	NULL
is	NULL
inhibited	NULL
by	NULL
phosphorylation	NULL
by	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Ca2+/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
.	NULL

J.	NULL
Neurosci	NULL
.	NULL

Res	NULL
.	NULL

34:642-647	NULL
.	NULL

14	NULL
.	NULL

Kumar	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Haque	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
J.	NULL
Hiscott	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Williams	NULL
.	NULL

1994	NULL
.	NULL

Double-stranded	NULL
RNA-dependent	NULL
protein	NULL
kinase	NULL
activates	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylating	NULL
IB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:6288-6292	NULL
.	NULL

15	NULL
.	NULL

Laurent-Winter	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Deschatrette	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
polypeptides	NULL
whose	NULL
presence	NULL
correlates	NULL
with	NULL
retention	NULL
or	NULL
loss	NULL
of	NULL
an	NULL
albumin	NULL
extinguisher	NULL
chromosome	NULL
in	NULL
rat	NULL
hepatoma-mouse	NULL
L	NULL
cell	NULL
fibroblast	NULL
microcell	NULL
hybrids	NULL
.	NULL

Differentiation	NULL
55:225-232	NULL
.	NULL

16	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
H.	NULL
S.	NULL
Choi	NULL
,	NULL
J.	NULL
Gyuris	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Moore	NULL
.	NULL

1995	NULL
.	NULL

Two	NULL
classes	NULL
of	NULL
proteins	NULL
dependent	NULL
on	NULL
either	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
thyroid	NULL
hormone	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

9243-254	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

REGULATION	NULL
OF	NULL
IxBa	NULL
DEGRADATION	NULL
5345	NULL
Lin	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
S.	NULL
Desiderio	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
activator	NULL
protein	NULL
RAG-2	NULL
by	NULL
phosphorylation	NULL
.	NULL

Science	NULL
260:953-959	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB	NULL
requires	NULL
proteolysis	NULL
of	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
signal-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
alone	NULL
does	NULL
not	NULL
release	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:552-556	NULL
.	NULL

18a.MacKichan	NULL
,	NULL
M.-L.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

McKinney	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
F.	NULL
Chang	NULL
,	NULL
N.	NULL
Heintz	NULL
,	NULL
and	NULL
F.	NULL
R.	NULL
Cross	NULL
.	NULL

1993	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
FAR1	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
yeast	NULL
cell	NULL
cycle	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:833-843	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
MAD3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-xB	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
M.	NULL
J.	NULL
Schmitt	NULL
,	NULL
M.	NULL
Hatanaka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
a	NULL
signal	NULL
for	NULL
its	NULL
degradation	NULL
but	NULL
not	NULL
dissociation	NULL
from	NULL
NF-xB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:12740-12744	NULL
.	NULL

Nishizawa	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Furuno	NULL
,	NULL
K.	NULL
Okazaki	NULL
,	NULL
H.	NULL
Tanaka	NULL
,	NULL
Y.	NULL
Ogawa	NULL
,	NULL
and	NULL
N.	NULL
Sagata	NULL
.	NULL

1993	NULL
.	NULL

Degradation	NULL
of	NULL
Mos	NULL
by	NULL
the	NULL
N-terminal	NULL
proline	NULL
(	NULL
Pro2	NULL
)	NULL
-dependent	NULL
ubiquitin	NULL
pathway	NULL
on	NULL
fertilization	NULL
of	NULL
Xenopus	NULL
eggs	NULL
:	NULL
possible	NULL
significance	NULL
of	NULL
natural	NULL
selection	NULL
for	NULL
Pro2	NULL
in	NULL
Mos	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4021-4027	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
78:773-785	NULL
.	NULL

Pollock	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
protein-DNA	NULL
binding	NULL
specificities	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:6197-6204	NULL
.	NULL

Rechsteiner	NULL
,	NULL
M.	NULL
1990	NULL
.	NULL

PEST	NULL
sequences	NULL
are	NULL
signals	NULL
for	NULL
rapid	NULL
intracellular	NULL
proteolysis	NULL
.	NULL

Semin	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

1:433-440	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Ernst	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IxBa	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4685-4695	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Rodriguez	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
I.	NULL
Michalopoulos	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

1995	NULL
.	NULL

Inducible	NULL
degradation	NULL
of	NULL
IxB	NULL
«	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
requires	NULL
the	NULL
acidic	NULL
C-terminal	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2413-2419	NULL
.	NULL

Schagger	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
G.	NULL
von	NULL
Jagow	NULL
.	NULL

1987	NULL
.	NULL

Tricine-sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
for	NULL
the	NULL
separation	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
range	NULL
from	NULL
1	NULL
to	NULL
100	NULL
kDa	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

166:368-379	NULL
.	NULL

Schwob	NULL
,	NULL
E.	NULL
,	NULL
T.	NULL
Bohm	NULL
,	NULL
M.	NULL
D.	NULL
Mendenhall	NULL
,	NULL
and	NULL
K.	NULL
Nasmyth	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B-type	NULL
cyclin	NULL
kinase	NULL
inhibitor	NULL
p40SIC1	NULL
controls	NULL
the	NULL
G1	NULL
to	NULL
S	NULL
transition	NULL
in	NULL
S.	NULL
cerevi-siae	NULL
.	NULL

Cell	NULL
79:233-244	NULL
.	NULL

Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p65-subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulates	NULL
IxB	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1266-1276	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405-430	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
;	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregula-tory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxBB	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573-582	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pabl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
Baeuerle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxBa	NULL
«	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxBa	NULL
proteolysis	NULL
and	NULL
NF-B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
EMBO	NULL
J	NULL
.	NULL

14:2876-2883	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5433-5441	NULL
.	NULL

